Startups
LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, and today, the company offers a wide range of therapies for all disease severities. For more information, visit www.leo-pharma.us and follow us on Twitter @LEOPharmaUS. Disclaimer: This site is intended for discussions about LEO Pharma US and the various initiatives LEO Pharma US is involved in. Due to regulations, discussions about pharmaceutical products are not allowed on this channel. All content must be factual and non-promotional. LEO Pharma US reserves the right to moderate or remove any content that may be inconsistent with legislation, industry ethics and regulations and LEO Pharma US’ values, including: - Profane or vulgar language - Insulting or offensive comments, such as displays of racism, calls to violence, hate propaganda, etc. - Commercial or political advertising - Copyright infringements, or any violation of the rights of external parties - automatically-generated content i.e. spam - Wrong/false statements For more information about our social media principles, please visit https://leo-pharma.com/social-media-principles To view our privacy policy, go to https://www.leo-pharma.us/Home/Privacy.aspx
Overview
Location
United States, New Jersey, Madison
Employees
5001-10000
Total raised
$65M
Founded date
1908
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 20, 2017 | Cognitive behavioral health startup Pacifica Labs closes seed round | Although the amount was not disclosed, the funding will be used in part to support Pacifica’s expansion from a direct to consumer platform to add resources for clinicians. Pacifica also plans to add telepsychiatry support tools to its platf... |
| Jun 8, 2016 | Cloud Therapy Uses Watson to Help Doctors, Pharma With Diagnoses | Share Share on Facebook Share on Twitter LinkedIn Email Reprints San Antonio — Andre Sandoval was born with a rare genetic condition. It was five months before his physician delivered a definitive diagnosis: he had a derivative of symphalan... |
| Jan 28, 2016 | LEO Pharma launches new innovation lab with $65M in funding for non-pharmaceutical dermatology expansion | Catalina Cernica, Head of Innovation Lab UK said in a statement: “With LEO Innovation Lab, the company is doubling down on innovating in beyond the pill products and services. We’re a separate unit with an agile approach and the mindset of ... |
| Jan 25, 2012 | Gel to treat precancerous skin condition gets FDA nod | Actinic keratosis can lead to squamous cell carcinoma, one of the leading types of skin cancer. In four phase 3 clinical studies of more than 1,000 patients with actinic keratosis, a significantly higher proportion of those treated with Pic... |
| Gel to treat precancerous skin condition gets FDA nod | A gel to treat a precancerous skin condition has been approved by the U.S. Food and Drug Administration. Picato gel, produced by LEO Pharma is applied to the skin to treat actinic keratosis, a skin condition caused by overexposure to the su... | |
| Cognitive behavioral health startup Pacifica Labs closes seed round | Pacifica for Clinicians from Pacifica Labs is a Software-a- a-Service, designed to help clinicians better track and treat their patients. Cognitive behavioral therapy startup Pacifica Labs has closed a seed round, led by LEO Innovation Lab,... | |
| Eying eczema, Amgen pays $400M to co-develop Phase 3-ready Kyowa Kirin drug | Amgen is vying to bolster its immunology drug portfolio and it is paying $400 million to do it. The sum gives it a share of an antibody from Kyowa Kirin that offers a new way of treating atopic dermatitis and potentially other inflammatory ... | |
| LEO Pharma launches new innovation lab with $65M in funding for non-pharmaceutical dermatology expansion | Denmark-based LEO Pharma, a well-established pharmaceutical company with a centered focus on skin care conditions, has announced a $65 million international initiative to take its already successful operation and put an effort into “beyond ... |
Reviews 0
FAQ about LEO Pharma US
When was LEO Pharma US founded?
LEO Pharma US was founded in 1908.
How much funding has LEO Pharma US raised?
LEO Pharma US has raised $65M in total across 1 funding round.
What has the press written about LEO Pharma US?
Parsers VC has collected 9 articles mentioning LEO Pharma US, among them “Cognitive behavioral health startup Pacifica Labs closes seed round” (Feb 20, 2017) and “Cloud Therapy Uses Watson to Help Doctors, Pharma With Diagnoses” (Jun 8, 2016).
Is LEO Pharma US still active?
Yes, LEO Pharma US is active; its latest activity on Parsers VC dates from Jun 1, 2021.